文献速递冠心病

高敏肌钙蛋白风险分层阈值在疑似急性冠脉综合征患者中的应用

High-Sensitivity Troponin and the Application of Risk Stratification Thresholds in Patients With Suspected Acute Coronary Syndrome.
PubMed 文献 · Circulation · 2019-09-01

结果显示两个阈值阴性预测值均高(99.8%和99.9%),且在年龄和性别亚组中一致;<5 ng/L和<2 ng/L患者12个月事件风险显著低于≥5 ng/L但<99百分位者。

要点

  • hs-cTnI<5 ng/L和<2 ng/L对30天心梗或心源性死亡的阴性预测值分别为99.8%和99.9%。
  • 两个阈值的阴性预测值在不同年龄和性别亚组中一致,但低危患者比例随年龄增长而下降。
  • 与≥5 ng/L但<99百分位者相比,<5 ng/L和<2 ng/L患者12个月心梗或心源性死亡风险分别降低77%和80%。

核心结论

  • 使用hs-cTnI风险分层阈值可识别症状持续至少2小时的疑似急性冠脉综合征低危患者,且不受年龄和性别影响。

研究设计与样本

  • 采用Abbott高敏肌钙蛋白I检测,比较检测限(<2 ng/L)和优化风险分层阈值(<5 ng/L)的表现。
  • 排除就诊时已有心肌损伤、症状≤2小时或ST段抬高型心肌梗死患者。

主要发现

  • 30天主要结局(心肌梗死或心源性死亡)阴性预测值:<5 ng/L为99.8%(95%CI 99.7%-99.8%),<2 ng/L为99.9%(95%CI 99.8%-99.9%)。
  • 两个阈值阴性预测值在男性和女性及所有年龄组中一致,但低危患者比例随年龄增长而下降。
  • 与hs-cTnI≥5 ng/L但<99百分位者相比,12个月心肌梗死或心源性死亡风险在<5 ng/L者低77%(5.3% vs 0.7%;调整OR 0.23 [95%CI 0.19-0.28]),在<2 ng/L者低80%(5.3% vs 0.3%;调整OR 0.20 [95%CI 0.14-0.29])。

临床怎么用

  • 对症状持续至少2小时的疑似急性冠脉综合征患者,就诊时hs-cTnI<5 ng/L或<2 ng/L可视为低危,辅助早期排除心肌梗死。
  • 风险分层阈值在不同年龄和性别中均可应用,但高龄患者达到低危阈值的比例较低,需结合临床综合判断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Guidelines acknowledge the emerging role of high-sensitivity cardiac troponin (hs-cTnl) for risk stratification and the early rule-out of myocardial infarction, but multiple thresholds have been described. We evaluate the safety and effectiveness of risk stratification thresholds in patients with suspected acute coronary syndrome. METHODS: Consecutive patients with suspected acute coronary syndrome (n=48 282) were enrolled in a multicenter trial across 10 hospitals in Scotland. In a prespecified secondary and observational analysis, we compared the performance of the limit of detection (<2 ng/L) and an optimized risk stratification threshold (<5 ng/L) using the Abbott high-sensitivity troponin I assay. Patients with myocardial injury at presentation, with ≤2 hours of symptoms or with ST-segment elevation myocardial infarction were excluded. The negative predictive value was determined in all patients and in subgroups for a primary outcome of myocardial infarction or cardiac death within 30 days. The secondary outcome was myocardial infarction or cardiac death at 12 months, with risk modeled using logistic regression adjusted for age and sex. RESULTS: In total, 32 837 consecutive patients (61±17 years, 47% female) were included, of whom 23 260 (71%) and 12,716 (39%) had hs-cTnl concentrations of <5 ng/L and <2 ng/L at presentation. The negative predictive value for the primary outcome was 99.8% (95% CI, 99.7%-99.8%) and 99.9% (95% CI, 99.8%-99.9%) in those with hs-cTnl concentrations of <5 ng/L and <2 ng/L, respectively. At both thresholds, the negative predictive value was consistent in men and women and across all age groups, although the proportion of patients identified as low risk fell with increasing age. Compared with patients with hs-cTnl concentrations of ≥5 ng/L but <99th centile, the risk of myocardial infarction or cardiac death at 12 months was 77% lower in those <5 ng/L (5.3% vs 0.7%; adjusted odds ratio, 0.23 [95% CI, 0.19-0.28]) and 80% lower in those <2 ng/L (5.3% vs 0.3%; adjusted odds ratio, 0.20 [95% CI, 0.14-0.29]). CONCLUSIONS: Use of risk stratification thresholds for hs-cTnl identify patients with suspected acute coronary syndrome and at least 2 hours of symptoms as low risk at presentation irrespective of age and sex. CLINICAL TRIAL REGISTRATION: URL: https://www.clinicaltrials.gov. Unique identifier: NCT01852123.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Bularga A, Lee KK, Stewart S, et al. High-Sensitivity Troponin and the Application of Risk Stratification Thresholds in Patients With Suspected Acute Coronary Syndrome. Circulation. 2019. PMID: 31475856. doi:10.1161/CIRCULATIONAHA.119.042866

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。